GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Mitophagy in Tumor Microenvironment

$380,062
Daolin Tang · Ut Southwestern Medical Center · R01 · FY2022 · CA

Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.

$380,041
Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2015 · HD

Keratins as novel determinants of tumor biology

$380,001
Pierre Coulombe · Johns Hopkins University · R01 · FY2015 · CA

PS03, a bifunctional RNA therapeutic to induce exhaustion in diabetogenic T cells

$380,000
Paolo Serafini · University Of Miami School Of Medicine · R56 · FY2025 · AI

Exploiting gold nanoparticle as a probe to identify therapeutic targets

$379,984
Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA

Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis

$379,977
Yi-Chieh Nancy Du · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA

Dectin-1 signaling drives pancreatic oncogenesis by inducing macrophage-mediated adaptive immune suppression

$379,977
Kwok Kin Wong · New York University School Of Medicine · R01 · FY2022 · CA

Mechanistic studies of transcription initiation and elongation functions of an RNA polymerase II variant, Pol II(G), that is implicated in development and cancer

$379,977
Robert G Roeder · Rockefeller University · R01 · FY2023 · CA

Personalization of graphical models using multi-omics data for subtype discovery and prognosis

$379,929
Tin C Nguyen · Auburn University At Auburn · U01 · FY2025 · CA

Transcriptomic origins of cancer

$379,915
Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Inhibition of CDK5 as a Treatment for Pancreatic Cancer

$379,900
Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2017 · CA

Novel Strategies for Pancreatic Cancer Treatment

$379,899
Jennifer D Black · University Of Nebraska Medical Center · P50 · FY2017 · CA

Targeting Metabolic Alterations to Improve Survival in Pancreatic Cancer

$379,895
Pankaj Kumar Singh · University Of Nebraska Medical Center · P50 · FY2017 · CA

Maturation of the Large Ribosomal Subunit in Yeast

$379,836
Arlen W Johnson · University Of Texas At Austin · R01 · FY2014 · GM

Nanotechnology Platforms for the Prevention and Personalized Therapy of Pancreati

$379,826
Craig D Logsdon · University Of Texas Hlth Sci Ctr Houston · U54 · FY2012 · CA

Magnetoresistive Sensor Platform for Parallel Cancer Marker Detection

$379,793
Marc D Porter · University Of Utah · U01 · FY2014 · CA

Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer

$379,725
Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R01 · FY2018 · CA

Synergistic targeting of cholesterol metabolism and EGFR signaling in cancer

$379,725
Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R01 · FY2017 · CA

IDO2 Targeting in Pancreatic Cancer

$379,675
George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2019 · CA

Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer

$379,660
Rebekah White · University Of California, San Diego · R01 · FY2023 · CA

Origins and functions of pancreatic cancer-associated fibroblasts

$379,585
Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Musashi-mediated control of pancreatic cancer growth and progression

$379,518
Tannishtha Reya · University Of California, San Diego · R01 · FY2015 · CA

Mechanisms of cancer cell chemotaxis in perineural invasion

$379,518
Richard J Wong · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA

Musashi-mediated control of pancreatic cancer growth and progression

$379,518
Tannishtha Reya · University Of California, San Diego · R01 · FY2017 · CA

Musashi-mediated control of pancreatic cancer growth and progression

$379,518
Tannishtha Reya · University Of California, San Diego · R01 · FY2018 · CA